Roche and Ignyta Reach Definitive Merger Agreement
Roche and Ignyta announced they have entered into a definitive merger agreement for Roche to fully acquire Ignyta at a price of US$ 27.00 per share in an all-cash transaction. This…
Read More...
Read More...
